-
Ganirelix acetate
-
BD01084437129311-55-399%
-
¥5863.0100mg
-
3-(5-((2,3-Difluoro-6-methoxybenzyl)oxy)-2-fluoro-4-methoxyphenyl)-2,4-dioxo-1,2,3,4-tetrahydrothieno[3,4-d]pyrimidine-5-carboxylic acid
-
BD01471526935283-04-898%
-
¥828.025mg
-
(8S,9R,10S,11S,13S,14S,17R)-17-Acetyl-9-fluoro-11-hydroxy-10,13-dimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl acetate
-
BD1305862529-45-598%
-
¥2990.01g
-
1-(4-(1-(2,6-Difluorobenzyl)-5-((dimethylamino)methyl)-3-(6-methoxypyridazin-3-yl)-2,4-dioxo-1,2,3,4-tetrahydrothieno[2,3-d]pyrimidin-6-yl)phenyl)-3-methoxyurea
-
BD585606737789-87-698%
-
¥1066.0100mg
-
(S)-N-((R)-1-Amino-1-oxopropan-2-yl)-1-((2S,5S,8R,11S,14S,17R,20R,23R)-20-(4-chlorobenzyl)-2-(3-guanidinopropyl)-11-(4-hydroxybenzyl)-14-(hydroxymethyl)-5-isobutyl-23-(naphthalen-2-ylmethyl)-4,7,10,13,16,19,22,25-octaoxo-17-(pyridin-3-ylmethyl)-8-(3-ureid
-
BD764624145672-81-799%
-
¥1351.010mg
-
Sodium (R)-4-((2-(5-(2-fluoro-3-methoxyphenyl)-3-(2-fluoro-6-(trifluoromethyl)benzyl)-4-methyl-2,6-dioxo-3,6-dihydropyrimidin-1(2H)-yl)-1-phenylethyl)amino)butanoate
-
BD636870832720-36-298%
-
¥719.0100mg
-
(S)-5-(4-Chlorophenyl)-N-(4-(4-fluorophenoxy)phenyl)-7,8-dihydro-1,6-naphthyridine-6(5H)-carboxamide
-
BD013118272471978-97-798%
-
¥24215.010mg
-
GnRH-R antagonist 1
-
BD023294372826273-90-798%
-
¥
-
BAY-784
-
BD013003301631164-24-398%
-
¥1825.05mg
-
Isopropyl 3-((benzyl(methyl)amino)methyl)-7-(2,6-difluorobenzyl)-2-(4-isobutyramidophenyl)-4-oxo-4,7-dihydrothieno[2,3-b]pyridine-5-carboxylate
-
BD01136003199119-18-198+%
-
¥
-
(S)-1-(((R)-2-((S)-2-((S)-2-((R)-2-((R)-2-((R)-2-Acetamido-3-(naphthalen-2-yl)propanamido)-3-(4-chlorophenyl)propanamido)-3-(pyridin-3-yl)propanamido)-3-hydroxypropanamido)-3-(4-hydroxyphenyl)propanamido)-5-ureidopentanoyl)-L-leucyl-L-arginyl)-N-((R)-1-amino-1-oxopropan-2-yl)pyrrolidine-2-carboxamide
-
BD111923120287-85-698+%
-
¥187.01mg
-
GnRH antagonist 2
-
BD014219771709823-61-998%
-
¥
-
(S)-N-((R)-1-Amino-1-oxopropan-2-yl)-1-((2S,5S,8R,11S,14S,17R,20R,23R)-20-(4-chlorobenzyl)-2-(3-guanidinopropyl)-11-(4-hydroxybenzyl)-14-(hydroxymethyl)-5-isobutyl-23-(naphthalen-2-ylmethyl)-4,7,10,13,16,19,22,25-octaoxo-17-(pyridin-3-ylmethyl)-8-(3-ureidopropyl)-3,6,9,12,15,18,21,24-octaazahexacosan-1-oyl)pyrrolidine-2-carboxamide diacetate
-
BD120522130143-01-099+%
-
¥740.050mg
-
(S)-N-((6S,9S,12R,15S,18S,21S,24S)-21-((1H-Indol-3-yl)methyl)-1,1-diamino-6-((S)-2-(2-carbamoylhydrazine-1-carbonyl)pyrrolidine-1-carbonyl)-15-(4-hydroxybenzyl)-12,18-bis(hydroxymethyl)-25-(1H-imidazol-5-yl)-9-isobutyl-8,11,14,17,20,23-hexaoxo-2,7,10,13,16,19,22-heptaazapentacos-1-en-24-yl)-5-oxopyrrolidine-2-carboxamide
-
BD0181703465807-03-698%
-
¥
-
(R)-4-((2-(5-(2-Fluoro-3-methoxyphenyl)-3-(2-fluoro-6-(trifluoromethyl)benzyl)-4-methyl-2,6-dioxo-3,6-dihydropyrimidin-1(2H)-yl)-1-phenylethyl)amino)butanoic acid
-
BD630884834153-87-698+%
-
¥5103.01g
-
(5-Oxopyrrolidine-2-carbonyl)histidyltryptophylseryltyrosylglycylleucylarginylprolylglycine
-
BD0141648335263-73-198%
-
¥
-
(R)-N1-((S)-1-(((S)-1-((S)-2-(((R)-1-Amino-1-oxopropan-2-yl)carbamoyl)pyrrolidin-1-yl)-6-(isopropylamino)-1-oxohexan-2-yl)amino)-4-methyl-1-oxopentan-2-yl)-2-((2S,5S,8R,11R,14R)-11-(4-chlorobenzyl)-2-(4-hydroxybenzyl)-5-(hydroxymethyl)-3-methyl-14-(naphthalen-2-ylmethyl)-4,7,10,13,16-pentaoxo-8-(pyridin-3-ylmethyl)-3,6,9,12,15-pentaazaheptadecanamido)succinamide
-
BD111905183552-38-798+%
-
¥3740.010mg
-
Antide
-
BD114486112568-12-499%
-
¥
-
(S)-6-Amino-2-((S)-2-((2S,3R)-2-amino-3-hydroxybutanamido)-3-hydroxypropanamido)hexanoic acid
-
BD11864971730-64-897%
-
¥8085.01g
-
Nbi-42902
-
BD01116216352290-60-999%
-
¥9209.010mg